Neoral Related Published Studies
Well-designed clinical trials related to Neoral (Cyclosporine)
Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome. [2008.11]
Dosing and safety of cyclosporine in patients with severe brain injury. [2008.10]
Effect of cyclosporine on reperfusion injury in acute myocardial infarction. [2008.07.31]
Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome. [2008.07.12]
CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A. [2008.06]
Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study. [2008.05.15]
Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multicenter trial. [2008.05]
Benefit of Neoral C2 monitoring in de novo cardiac transplant recipients receiving basiliximab induction. [2008.04.15]
Cyclosporine 0.05% ophthalmic preparation to aid recovery from loss of corneal sensitivity after LASIK. [2008.04]
Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine. [2008.04]
Urinary epidermal growth factor and interleukin-6 levels in patients with painful bladder syndrome/interstitial cystitis treated with cyclosporine or pentosan polysulfate sodium. [2008.04]
Prospective comparison of the use of sirolimus and cyclosporine in recipients of a kidney from an expanded criteria donor. [2008.02.15]
A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients. [2008.02]
A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine. [2008.02]
Effect of multiple oral dosing of fluconazole on the pharmacokinetics of cyclosporine in healthy beagles. [2008.01]
Cyclosporine pharmacokinetics and blood pressure responses after conversion to once-daily dosing in maintenance liver transplant patients. [2008.01]
Efficacy of cyclosporine 0.05% ophthalmic emulsion in contact lens wearers with dry eyes. [2008.01]
A comparison of combination therapy (cyclosporine plus prednisolone) with sole prednisolone therapy in 7 dogs with necrotizing meningoencephalitis. [2007.12]
Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia. [2007.12]
Conversion of cyclosporine to tacrolimus in stable renal allograft recipients: quantification of effects on the severity of gingival enlargement and hirsutism and patient-reported outcomes. [2007.12]
Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids. [2007.11]
Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury. [2007.10.27]
A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation. [2007.10]
Quantification of interstitial fibrosis by image analysis on routine renal biopsy 1 year after transplantation in patients managed by C2 monitoring of cyclosporine microemulsion. [2007.10]
Three-year health-related quality-of-life outcomes for sirolimus-treated kidney transplant patients after elimination of cyclosporine. [2007.10]
Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression. [2007.09.27]
Early sirolimus use with cyclosporine elimination does not induce progressive proteinuria. [2007.09]
Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye. [2007.08]
Neoimmun versus Neoral: a bioequivalence study in healthy volunteers and influence of a fat-rich meal on the bioavailability of Neoimmun. [2007.08]
Randomized trial of low-dose interleukin-2 vs cyclosporine A and interferon-gamma after high-dose chemotherapy with peripheral blood progenitor support in women with high-risk primary breast cancer. [2007.08]
Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: efficacy and safety. [2007.07.15]
Apparent low absorbers of cyclosporine microemulsion have higher requirements for tacrolimus in renal transplantation. [2007.07]
The effect of sirolimus- or cyclosporine-based immunosuppression effects on T-cell subsets in vivo. [2007.07]
Efficacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgaris. [2007.07]
Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience. [2007.06]
Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. [2007.06]
Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus-based therapy: a multivariate analysis of results at five years. [2007.05]
Renal function with delayed or immediate cyclosporine microemulsion in combination with enteric-coated mycophenolate sodium and steroids: results of follow up to 30 months post-transplant. [2007.05]
Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data. [2007.03.15]
Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial. [2007.03]
Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximab. [2007.03]
Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study. [2007.03]
One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients. [2007.03]
Effect of topical cyclosporine on tear functions in tear-deficient dry eyes. [2007.03]
Potassium sensitivity test (PST) as a measurement of treatment efficacy of painful bladder syndrome/interstitial cystitis: a prospective study with cyclosporine A and pentosan polysulfate sodium. [2007]
A comparison of two cyclosporine dosage regimens for the treatment of severe psoriasis. [2007]
Comparison of azithromycin and oral hygiene program in the treatment of cyclosporine-induced gingival hyperplasia. [2007]
Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation. [2006.12]
Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis. [2006.12]
FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and Australasia. [2006.12]
Impact of Cyclosporine Reduction With MMF: A Randomized Trial in Chronic Allograft Dysfunction. The 'Reference' Study. [2006.11]
Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood. [2006.11]
Cyclosporine withdrawal improves renal function in heart transplant patients on reduced-dose cyclosporine therapy. [2006.11]
FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1-Year, Randomized Controlled Trial in Europe and Australasia. [2006.10.25]
Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. [2006.10]
Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes. [2006.10]
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. [2006.10]
Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial. [2006.09.15]
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. [2006.09]
Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine. [2006.08.27]
Evaluation of the effect of two dose rates of cyclosporine on the severity of perianal fistulae lesions and associated clinical signs in dogs. [2006.08]
Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients. [2006.08]
FTY720/cyclosporine regimens in de novo renal transplantation: a 1-year dose-finding study. [2006.08]
A randomized controlled trial to compare steroid with cyclosporine for the topical treatment of oral lichen planus. [2006.07]
Drug-drug interaction after single oral doses of the furanocoumarin methoxsalen and cyclosporine. [2006.07]
Treatment of cyclosporine-induced gingival overgrowth with azithromycin-containing toothpaste. [2006.06]
Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteers. [2006.06]
Steroid withdrawal in living donor renal transplant recipients using tacrolimus and cyclosporine: a randomized prospective study. [2006.06]
Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients--a large European trial. [2006.06]
Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. [2006.06]
Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis. [2006.05]
Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. [2006.05]
Sympathetic nerve activity in renal transplant patients before and after withdrawal of cyclosporine. [2006.05]
Impact of early or delayed cyclosporine on delayed graft function in renal transplant recipients: a randomized, multicenter study. [2006.05]
Coronary endothelial vasomotor function and vascular remodeling in heart transplant recipients randomized for tacrolimus or cyclosporine immunosuppression. [2006.04.18]
Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial. [2006.04.15]
Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: a prospective randomized single-center pilot study. [2006.04.15]
Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients. [2006.04]
Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial. [2006.04]
Assessment of the bioequivalence of a generic cyclosporine A by a randomized controlled trial in stable renal recipients. [2006.03.15]
Use of cyclosporine 0.05% ophthalmic emulsion for contact lens-intolerant patients. [2006.03]
Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. [2006.03]
Combination of cyclosporine and leflunomide versus single therapy in severe rheumatoid arthritis. [2006.03]
Interaction of single-dose ezetimibe and steady-state cyclosporine in renal transplant patients. [2006.03]
Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. [2006.02]
Efficacy of commercially available topical cyclosporine a 0.05% in the treatment of meibomian gland dysfunction. [2006.02]
A randomized trial of inhaled cyclosporine in lung-transplant recipients. [2006.01.12]
Prospective, randomized trial of steroid withdrawal in kidney recipients treated with mycophenolate mofetil and cyclosporine. [2006.01]
An evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marketed artificial tears as supportive therapy in dry eye. [2006.01]
No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year. [2006.01]
Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases. [2006.01]
A randomized, controlled trial of C0- Vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients. [2005.12]
Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. [2005.12]
Association between cyclosporine concentrations at 2 hours post-dose and clinical outcomes in de novo lung transplant recipients. [2005.12]
Influence of co-medication with sirolimus or cyclosporine on mycophenolic acid pharmacokinetics in kidney transplantation. [2005.12]
Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function. [2005.11.15]
Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation. [2005.11]
A multicenter, prospective study of C2-monitored cyclosporine microemulsion in a U.S. population of de novo renal transplant recipients. [2005.10.15]
[Cyclosporine microemulsion C2 monitoring in Chinese adult liver transplant recipients: a preliminary randomized control trial] [2005.10.01]
Cyclosporine markedly raises the plasma concentrations of repaglinide. [2005.10]
The utility of the population approach applied to bioequivalence in patients: comparison of 2 formulations of cyclosporine. [2005.10]
|
